BRPI0822485A2 - Composição farmacêutica para prevenção de disbiose associada com administração enteral de antibióticos. - Google Patents

Composição farmacêutica para prevenção de disbiose associada com administração enteral de antibióticos.

Info

Publication number
BRPI0822485A2
BRPI0822485A2 BRPI0822485-4A BRPI0822485A BRPI0822485A2 BR PI0822485 A2 BRPI0822485 A2 BR PI0822485A2 BR PI0822485 A BRPI0822485 A BR PI0822485A BR PI0822485 A2 BRPI0822485 A2 BR PI0822485A2
Authority
BR
Brazil
Prior art keywords
antibiotics
prevention
pharmaceutical composition
enteral administration
dysbiosis associated
Prior art date
Application number
BRPI0822485-4A
Other languages
English (en)
Inventor
Oleg Valentinovich Dorozhko
Boris Anatolievich Rudoi
Aleksander Vladimirovich Dikovskiy
Original Assignee
Aleksander Vladimirovich Dikovskiy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aleksander Vladimirovich Dikovskiy filed Critical Aleksander Vladimirovich Dikovskiy
Publication of BRPI0822485A2 publication Critical patent/BRPI0822485A2/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/702Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0822485-4A 2008-03-18 2008-03-18 Composição farmacêutica para prevenção de disbiose associada com administração enteral de antibióticos. BRPI0822485A2 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/RU2008/000151 WO2009116886A1 (ru) 2008-03-18 2008-03-18 Фармацевтическая композиция и способ профилактики дисбиозов, ассоциированных с энтеральным приемом антибиотиков

Publications (1)

Publication Number Publication Date
BRPI0822485A2 true BRPI0822485A2 (pt) 2015-06-16

Family

ID=41091125

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0822485-4A BRPI0822485A2 (pt) 2008-03-18 2008-03-18 Composição farmacêutica para prevenção de disbiose associada com administração enteral de antibióticos.

Country Status (13)

Country Link
US (1) US20110200668A1 (pt)
EP (1) EP2266582B1 (pt)
CN (1) CN101998859B (pt)
BR (1) BRPI0822485A2 (pt)
DK (1) DK2266582T3 (pt)
EA (1) EA020023B1 (pt)
ES (1) ES2542879T3 (pt)
HR (1) HRP20150811T1 (pt)
HU (1) HUE025097T2 (pt)
PL (1) PL2266582T3 (pt)
PT (1) PT2266582E (pt)
UA (1) UA98215C2 (pt)
WO (1) WO2009116886A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2804258T3 (es) 2010-12-31 2021-02-05 Abbott Lab Procedimientos para reducir la incidencia de estrés oxidativo usando oligosacáridos de leche humana, vitamina C y agentes antiinflamatorios
CN107019701B (zh) 2010-12-31 2020-07-28 雅培制药有限公司 使用人乳低聚糖来降低婴儿、幼儿或儿童的坏死性小肠结肠炎的发病率的方法
EP2734210B1 (en) * 2011-07-22 2017-11-22 Abbott Laboratories Galactooligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
CA2846603A1 (en) 2011-08-29 2013-03-07 Abbott Laboratories Human milk oligosaccharides for preventing injury and/or promoting healing of the gastrointestinal tract
WO2013087319A2 (de) 2011-12-13 2013-06-20 Henkel Ag & Co. Kgaa Zusammensetzungen zur färbung keratinhaltiger fasern
GB201305708D0 (en) * 2013-03-28 2013-05-15 Clasado Inc Novel use
CN108186661A (zh) * 2017-12-15 2018-06-22 哈尔滨珍宝制药有限公司 一种包含盐酸克林霉素的药物组合物及其制备方法
RU2675631C1 (ru) * 2018-10-02 2018-12-21 Общество с ограниченной ответственностью "Новые Биомедицинские Решения" Местное гемостатическое средство с повышенной антимикробной активностью
US12343432B2 (en) * 2023-07-07 2025-07-01 United Arab Emirates University Encapsulated probiotic

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5861172A (en) * 1991-05-08 1999-01-19 Laboratorios Beecham Sa Pharmaceutical formulations of compacted granulates of β-lactam antibiotics
IT1271449B (it) * 1993-04-28 1997-05-28 Inalco Spa Procedimento per la preparazione di lattulosio cristallino da sciroppi commerciali
US5827526A (en) * 1995-07-11 1998-10-27 Abbott Laboratories Use of indigestible oligosaccharides to prevent gastrointestinal infections and reduce duration of diarrhea in humans
US6461607B1 (en) * 1998-08-24 2002-10-08 Ganeden Biotech, Inc. Probiotic, lactic acid-producing bacteria and uses thereof
DE60031385D1 (de) * 2000-06-28 2006-11-30 B S D Bio Science Dev Snc Di O Pharmazeutische Zusammensetzungen von Antibiotika und Fruktan-Gemische
EP1355542B2 (en) * 2000-12-27 2012-04-04 N.V. Nutricia Nutritional composition with health promoting action containing oligosaccharides
IL161996A0 (en) * 2001-12-21 2005-11-20 Pfizer Prod Inc Directly compressible formulations of azithromycin
ITBO20020564A1 (it) * 2002-09-06 2004-03-07 Alfa Wassermann Spa Bifidobatteri e preparazioni che li contengono.
RU2284832C2 (ru) * 2004-08-30 2006-10-10 Николай Александрович Киселев Антимикробная композиция для перорального введения

Also Published As

Publication number Publication date
EP2266582B1 (en) 2015-04-29
HRP20150811T1 (hr) 2015-09-11
WO2009116886A1 (ru) 2009-09-24
DK2266582T3 (en) 2015-07-27
US20110200668A1 (en) 2011-08-18
ES2542879T3 (es) 2015-08-12
PT2266582E (pt) 2015-09-04
PL2266582T3 (pl) 2015-10-30
EA201001099A1 (ru) 2011-02-28
UA98215C2 (ru) 2012-04-25
EA020023B1 (ru) 2014-08-29
CN101998859B (zh) 2014-03-05
CN101998859A (zh) 2011-03-30
EP2266582A4 (en) 2011-03-02
EP2266582A1 (en) 2010-12-29
HUE025097T2 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
IL275854A (en) Pharmaceutical composition and its administration
EP2381773A4 (en) COMPOSITIONS FOR THE ADMINISTRATION OF MEDICINAL PRODUCTS
DK1983964T3 (da) Anordning til indgivelse af lægemiddel
IL204844A (en) Coinolone analogues, pharmaceuticals containing them and their uses
WO2009074300A8 (en) Hedgehog pathway antagonists and therapeutic applications thereof
DK2346495T4 (da) Farmaceutisk formulering 514
BRPI1009823A2 (pt) "composição compreendendo um sistema de dispensação de droga, conjunto de uma primeira e uma segunda composição, e, kit."
BRPI1014865A2 (pt) "composição e formulação farmacêutica comreendendo derivados de nitrocatecol, e, método para fabricar uma composição ou formulação farmacêutica"
IL206808A (en) Indolyl-pyridone history, their pharmaceutical preparations and their uses
BRPI0809661A2 (pt) Composição farmacêutica estabilizada contendo pregabalina
DK2120884T3 (da) Farmaceutisk sammensætning
BR112012003800A2 (pt) composição, peptídeo, e formulação farmacêutica.
DK2482881T3 (da) Mekanisme til indretning til indlevering af lægemiddel
BRPI0817833A2 (pt) Composição farmacêutica antimalárica
PT2266582E (pt) Composição farmacêutica para a prevenção da disbiose associada à administração enteral de antibióticos
BRPI1007484A2 (pt) composição farmacêutica para administração oral
BRPI0916571A2 (pt) composto derivado de alquilaminometiloxazolidinona tricíclo, medicamento e composição farmacêutica que o contém e uso do composto
BRPI0812234A2 (pt) Composto de quinolona e composição farmacêutica.
CR20130174A (es) Sistema y composiciones mejorados para la administración transbucal de fármacos
IL197732A0 (en) Packaging system for pharmaceutical compositions for intravenous administration and kits comprising the same
IL208788A (en) Pharmacy-based formulation
BRPI0923675A2 (pt) formulação para administração de medicamento com baixa quantidade de lipídeos por via transmucosal oral
BR112012021455A2 (pt) formulação farmacêutica ou nutracêutica.
EP2275092A4 (en) PHARMACEUTICAL TAX FORMULATION
ZA200809269B (en) Liquid pharmaceutical formulation

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL